Seguir
Rajeshkumar NV
Título
Citado por
Citado por
Año
Gemcitabine plus nab-paclitaxel is an active regimen in patients with advanced pancreatic cancer: a phase I/II trial
DD Von Hoff, RK Ramanathan, MJ Borad, DA Laheru, LS Smith, TE Wood, ...
Journal of Clinical Oncology 29 (34), 4548, 2011
12272011
Prognostic significance of tumorigenic cells with mesenchymal features in pancreatic adenocarcinoma
ZA Rasheed, J Yang, Q Wang, J Kowalski, I Freed, C Murter, SM Hong, ...
Journal of the National Cancer Institute 102 (5), 340-351, 2010
5262010
Autophagy is critical for pancreatic tumor growth and progression in tumors with p53 alterations
A Yang, NV Rajeshkumar, X Wang, S Yabuuchi, BM Alexander, GC Chu, ...
Cancer discovery 4 (8), 905-913, 2014
4572014
A pilot clinical study of treatment guided by personalized tumorgrafts in patients with advanced cancer
M Hidalgo, E Bruckheimer, NV Rajeshkumar, I Garrido-Laguna, ...
Molecular cancer therapeutics 10 (8), 1311-1316, 2011
4552011
Antitumour and anticarcinogenic activity of Phyllanthus amarus extract
NV Rajeshkumar, KL Joy, G Kuttan, RS Ramsewak, MG Nair, R Kuttan
Journal of Ethnopharmacology 81 (1), 17-22, 2002
3062002
Personalizing Cancer Treatment in the Age of Global Genomic Analyses: PALB2 Gene Mutations and the Response to DNA Damaging Agents in Pancreatic Cancer
MC Villarroel, NV Rajeshkumar, I Garrido-Laguna, A De Jesus-Acosta, ...
Molecular cancer therapeutics 10 (1), 3-8, 2011
2902011
MK-1775, a potent Wee1 inhibitor, synergizes with gemcitabine to achieve tumor regressions, selectively in p53-deficient pancreatic cancer xenografts
NV Rajeshkumar, E De Oliveira, N Ottenhof, J Watters, D Brooks, ...
Clinical cancer research 17 (9), 2799-2806, 2011
2862011
Tumor-initiating cells are rare in many human tumors
K Ishizawa, ZA Rasheed, R Karisch, Q Wang, J Kowalski, E Susky, ...
Cell stem cell 7 (3), 279-282, 2010
2732010
Tumor engraftment in nude mice and enrichment in stroma-related gene pathways predict poor survival and resistance to gemcitabine in patients with pancreatic cancer
I Garrido-Laguna, M Uson, NV Rajeshkumar, AC Tan, E De Oliveira, ...
Clinical Cancer Research 17 (17), 5793-5800, 2011
2662011
Inhibition of chemical carcinogenesis by berberine in rats and mice
KV Anis, NV Rajeshkumar, R Kuttan
Journal of Pharmacy and Pharmacology 53 (5), 763-768, 2001
2322001
Characterizing DNA methylation patterns in pancreatic cancer genome
AC Tan, A Jimeno, SH Lin, J Wheelhouse, F Chan, A Solomon, ...
Molecular oncology 3 (5-6), 425-438, 2009
1822009
Therapeutic targeting of the Warburg effect in pancreatic cancer relies on an absence of p53 function
NV Rajeshkumar, P Dutta, S Yabuuchi, RF De Wilde, GV Martinez, A Le, ...
Cancer research 75 (16), 3355-3364, 2015
1622015
Notch signaling pathway targeted therapy suppresses tumor progression and metastatic spread in pancreatic cancer
S Yabuuchi, SG Pai, NR Campbell, RF De Wilde, E De Oliveira, ...
Cancer letters 335 (1), 41-51, 2013
1572013
Cyclin-dependent kinase inhibitor Dinaciclib (SCH727965) inhibits pancreatic cancer growth and progression in murine xenograft models
G Feldmann, A Mishra, S Bisht, C Karikari, I Garrido-Laguna, Z Rasheed, ...
Cancer biology & therapy 12 (7), 598-609, 2011
1362011
Phyllanthus amarus extract administration increases the life span of rats with hepatocellular carcinoma
NV Rajeshkumar, R Kuttan
Journal of ethnopharmacology 73 (1-2), 215-219, 2000
1352000
Small-molecule inhibition of Axl targets tumor immune suppression and enhances chemotherapy in pancreatic cancer
KF Ludwig, W Du, NB Sorrelle, K Wnuk-Lipinska, M Topalovski, ...
Cancer research 78 (1), 246-255, 2018
1302018
Phase 2 study of vismodegib, a hedgehog inhibitor, combined with gemcitabine and nab-paclitaxel in patients with untreated metastatic pancreatic adenocarcinoma
A De Jesus-Acosta, EA Sugar, PJ O’Dwyer, RK Ramanathan, ...
British journal of cancer 122 (4), 498-505, 2020
1242020
Impact of APE1/Ref-1 redox inhibition on pancreatic tumor growth
ML Fishel, Y Jiang, NV Rajeshkumar, G Scandura, AL Sinn, Y He, C Shen, ...
Molecular cancer therapeutics 10 (9), 1698-1708, 2011
1232011
Coordinated epidermal growth factor receptor pathway gene overexpression predicts epidermal growth factor receptor inhibitor sensitivity in pancreatic cancer
A Jimeno, AC Tan, J Coffa, NV Rajeshkumar, P Kulesza, ...
Cancer research 68 (8), 2841-2849, 2008
1212008
Integrated preclinical and clinical development of S-trans, trans-Farnesylthiosalicylic Acid (FTS, Salirasib) in pancreatic cancer
D Laheru, P Shah, NV Rajeshkumar, F McAllister, G Taylor, H Goldsweig, ...
Investigational new drugs 30 (6), 2391-2399, 2012
1162012
El sistema no puede realizar la operación en estos momentos. Inténtalo de nuevo más tarde.
Artículos 1–20